Antitrust regulators clear Quest Diagnostics, Celera merger
Medical laboratory operator Quest Diagnostics’ acquisition of Celera, a genetic diagnostics discovery and development company, was cleared today by the Federal Trade Commission.Medical laboratory operator Quest Diagnostics’ acquisition of Celera, a...To view the full article, register now.
Already a subscriber? Click here to view full article